Eli Lilly's digital boss admits that AI has so far brought advantages in the pharmaceutical industry, especially where it is not about drug search. The article Digital Twin instead of Miracle Molecule: AI has so far had more effect in pharmaceutical production than in research, first appeared on The Decoder.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
Eli Lilly's digital boss admits that AI has so far brought advantages in the pharmaceutical industry, especially where it is not about drug search. The article Digital Twin instead of Miracle Molecule: AI has so far had more effect in pharmaceutical production than in research, first appeared on The Decoder.